FDA Inspection 1209565 — Grifols
The FDA completed an inspection of Grifols on June 2, 2023 in Fort Walton Beach, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 2, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Fort Walton Beach, FL (United States)